Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.66 is 61% above its 2-year average of 5.37, near the high end of its 2-year range (0.00–11.91).
As of the fiscal period ended Tuesday, June 30, 2026. 5.35% below its 12-month average of 9.15.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.66.
QUICK RATIO (ACID-TEST)
8.66
QUICK RATIO (ACID-TEST) AVG TTM
9.15
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.35%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 759 covered companies
CURRENT VS SECTOR MEDIAN
+171.38%
vs the sector median at left
Market Cap
$410.85M
Quick Ratio (Acid-Test)
1.98
TTM Avg
1.95
3Y Avg
1.91
5Y Avg
2.07
Market Cap
$410.80M
Quick Ratio (Acid-Test)
10.64
TTM Avg
18.70
3Y Avg
14.71
5Y Avg
15.03
Market Cap
$411.45M
Quick Ratio (Acid-Test)
8.92
TTM Avg
6.16
3Y Avg
7.06
5Y Avg
7.06
Market Cap
$412.94M
Quick Ratio (Acid-Test)
8.13
TTM Avg
16.34
3Y Avg
21.67
5Y Avg
17.16
Market Cap
$396.99M
Quick Ratio (Acid-Test)
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
Market Cap
$414.16M
Quick Ratio (Acid-Test)
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$419.05M
Quick Ratio (Acid-Test)
25.05
TTM Avg
8.87
3Y Avg
10.83
5Y Avg
12.06
Market Cap
$390.83M
Quick Ratio (Acid-Test)
2.86
TTM Avg
2.54
3Y Avg
2.71
5Y Avg
3.53
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Carlsmed, Inc. (CARL) | $404.78M | 8.66 | 9.15 | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $410.85M | 1.98 | 1.95 | 1.91 | 2.07 |
| Neurogene Inc. (NGNE)vs › | $410.80M | 10.64 | 18.70 | 14.71 | 15.03 |
| Shoulder Innovations, Inc. (SI)vs › | $411.45M | 8.92 | 6.16 | 7.06 | 7.06 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $412.94M | 8.13 | 16.34 | 21.67 | 17.16 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $396.99M | 16.52 | 13.61 | 8.86 | 8.86 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $414.16M | 9.89 | 6.34 | 6.34 | 6.34 |
| Prothena Corporation plc (PRTA)vs › | $419.05M | 25.05 | 8.87 | 10.83 | 12.06 |
| REGENXBIO Inc. (RGNX)vs › | $390.83M | 2.86 | 2.54 | 2.71 | 3.53 |
| Rezolute, Inc. (RZLT)vs › | $421.28M | 9.44 | 11.90 | 14.34 | 23.42 |
Quick Ratio
8.66
Excludes inventory
Current Ratio
8.84
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.66 |
| 2026-03-31 | 11.67 |
| 2025-12-31 | 8.74 |
| 2025-09-30 | 11.91 |
| 2025-06-30 | 4.76 |
| 2025-03-31 | 6.33 |
| 2024-12-31 | 5.48 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 1.50 |
